Vaccines: Engineering immune evasion

Nature

Volumn 441, Issue 7090, 2006, Pages 161-162

  Mascola, John R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; VACCINE; VIRUS VACCINE; VIRUS VECTOR;

IMMUNE RESPONSE; PHARMACEUTICAL INDUSTRY; VACCINE;

BIOENGINEERING; CELLULAR IMMUNITY; DRUG DELIVERY SYSTEM; IMMUNITY; IMMUNOGENICITY; PRIORITY JOURNAL; SHORT SURVEY; VIRUS RECOMBINANT;

ADENOVIRIDAE;

EID: 33646597758     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/441161a     Document Type: Short Survey

References (8)

1. Roberts, D. M. et al. Nature 441, 239-243 (2006).
2. Casimiro, D. R. et al. J. Virol. 77, 7663-7668 (2003).
3. Santra, S. et al. J. Virol. 79, 6516-6522 (2005).
4. Bangari, D. S. & Mittal, S. K. Vaccine 24, 849-862 (2006).
5. Shiver, J. W. & Emini, E. A. Annu. Rev. Med 55, 355-372 (2004).
6. Barouch, D. H. & Nabel, G. J. Hum. Gene Ther. 16, 149-156 (2005).
7. Sullivan, N. J. et al. Nature 424, 681-684 (2003).
8. Lemckert, A. A. et al. J. Virol. 79, 9694-9701 (2005).